Ken Griffin Hyperfine, Inc. Call Options Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Call Options

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$0.9 - $1.24 $180 - $248	200 Added 22.22%	1,100 $1,000
Q2 2024 Aug 14, 2024	SELL	$0.79 - $1.02 $1,422 - $1,836	-1,800 Reduced 66.67%	900 $0
Q1 2024 May 15, 2024	BUY	$0.96 - $1.25 $2,592 - $3,375	2,700 New	2,700 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.81 - $2.06 $11,664 - $29,664	14,400 New	14,400 $12,000

Others Institutions Holding HYPR

# of Institutions

43

Shares Held

14.1M

Call Options Held

11.1K

Put Options Held

0

Health Cor Management, L.P. New York, NY

3.88M
Shares

$3.45 Million
3.08% of portfolio
Vanguard Group Inc Valley Forge, PA

3.18M
Shares

$2.83 Million
0.0% of portfolio
Fosun International LTD

1.74M
Shares

$1.55 Million
1.78% of portfolio
Avidity Partners Management LP Dallas, TX

1.19M
Shares

$1.06 Million
0.08% of portfolio
Alphabet Inc. Mountain View, CA

899K
Shares

$799,860
0.07% of portfolio

About Hyperfine, Inc.

Ticker HYPR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,515,500
Market Cap $49.4M
Description
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

More about HYPR

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.